• Join
  • Login
  • Contact

Search abstracts

Intralesional methotrexate for keratoacanthoma of the face

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: HPS-068
  • Co-author(s): Dra. SOL CORTES DE MIGUEL, PHARMACY (Hospital Punta Europa, Algeciras, Spain)
    Dr. ALBERTO SORIA MARTÍN, FARMACIA (Hospital Punta Europa, Algeciras, Spain)
    Dr ADRIANA MORENO HERRERA, PHARMACY (Hospital Punta Europa, Algeciras, Spain)
  • Abstract:

    Background information
    Keratoacanthomas (KA) are self-regressing, destructively expanding keratinocyte skin neoplasms typically characterized by sudden onset of explosive growth followed by complete involution. Although many treatment modalities have been described, surgical excision is currently the treatment of choice for the majority of..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses